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Background: Invasive cardiac procedures, such as arrhythmia ablation, cardiac 
resynchronisation therapy, percutaneous mitral annuloplasty and retrograde 
cardioplegia delivery require cannulation of the coronary sinus (CS). Detailed 
knowledge of the CS ostium region, including recognition of the presence of the 
Thebesian valve which sometimes covers the sinus, is a key to successfully carry 
out such procedures. 
Materials and methods: In the present study, 160 autopsied human hearts from 
both sexes were examined for the presence of the Thebesian valve. If identified, 
the histological structure of the valve was studied. 
Results: Five types of the CS valve were distinguished; all of them presented with 
a typical histological structure with the exception of the cord-like type, in which 
cells were similar to those of the conduction system of the heart. 
Conclusions: Proper identification of the CS valve and analysis of its size and 
histological features could have important implications for electrophysiologists. 
(Folia Morphol 2014; 73, 3: 298–301)
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INTRODUCTION
The coronary sinus (CS) is the main venous vessel 
of the heart, receiving about 60% of the blood retur-
ning to the right atrium. It is located in the posterior 
part of the coronary groove, between the left ven-
tricle and the left atrium. The ostium of this sinus is 
situated in the angle between the inferior and medial 
walls of the right atrium and above the opening for 
the inferior vena cava. Sometimes the opening of 
the CS is guarded by a valve of variable morphology 
and size, known as the Thebesian valve, which is 
a remnant of the right valve of the venous sinus [9, 
15, 16]. There is a great deal of variability within the 
coronary venous system that usually does not have 
any clinical importance. However, in procedures such 
as arrhythmia ablation, cardiac resynchronisation the-
rapy (CRT) and cardioplegia delivery, variability in this 
region may contribute to the difficulties that can be 
encountered during CS cannulation. The development 
of effective and dynamic invasive cardiology requires 
detailed descriptions of this region and appraisal of 
the clinical significance of its morphology [4, 5, 10, 
14]. Thus, the aim of this study was to examine the 
correlation between the structure of the Thebesian 
valve and unsuccessful CS cannulation.
MATERIALS AND METHODS
The research was conducted on 160 autopsied hu-
man hearts from both sexes, aged 17–70. Eighty three 
per cent of specimens were from male cadavers while 
17% were obtained from female cadavers. The study 
protocol was approved by the local ethics committee 
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No. KBET\40\B\2007. Only hearts without any defects 
or macroscopically visible pathology from individuals 
whose cause of death was not cardiological in nature 
were examined. Classic anatomical techniques were 
performed. To uncover the region of CS ostium, an 
incision was made from the right auricle to the superior 
vena cava opening. Presence and morphology of the 
Thebesian valve was noted and documented photo-
graphically. The CS valves were dissected and used in hi-
stological preparations. Tissues samples of 1 cm × 1 cm 
were taken and preserved in 10% formalin solution 
before being hardened in paraffin. Subsequently hi-
stological preparations were sliced longitudinally and 
stained in haematoxylin–eosin solution in Masson’s 
modification. All preparations were microscopically 
examined and documented photographically.
RESULTS
A well-developed CS was observed in all the he-
arts with the ostium extending into the right atrium. 
Within the ostium, on the right side of its circum-
ference, a variably developed Thebesian valve was 
found. In 36 (22.5%) specimens the valve was absent. 
Five types of the Thebesian valve were distinguished 
based on morphology. Absence of the CS valve was 
classified as type I. Type II looked like a cord or strand, 
sometimes dividing the orifice into two parts. Type 
III was composed of a very small rudimentary pie-
ce of endocardium. In some hearts, the Thebesian 
valve was well-developed and semilunar in shape; 
this was classified as type IV. Lastly, type V valves 
were big, usually covered the ostium, and resembled 
a fold. The semilunar valve (type IV) was the most 
frequently observed morphology of the Thebesian 
valve observed in 27.5% of hearts. The least common 
conformations were the type II strands which were 
found in only 12.5% of specimens. All histological pre-
parations obtained from types III, IV and V revealed 
a structure typical for the CS valve: a surface lined 
with endocardium, collagen and elastic fibres, and 
myocardial cells (Fig. 1). In type II strand valves, cells 
rich in sarcoplasm with big dark staining nuclei were 
observed (Figs. 2, 3). These cells resembled those of 
conduction system of the heart.
DISCUSSION
Development of invasive cardiac procedures led 
electrophysiologists to focus more attention on the 
anatomy of the CS ostium, especially the opening 
into the right atrium. Access to the CS via its orifice is 
essential in CRT, electrophysiological study, cardiova-
scular angiographic analysis, and percutaneous mitral 
annuloplasty [6, 17]. Clinicians are challenged by the 
Figure 3. Histological structure of the strand-like valve stained in 
haematoxylin–eosin solution in Masson’s modification.
Figure 1. Typical histological structure of the coronary sinus valve 
stained in haematoxylin–eosin solution.
Figure 2. Histological structure of the strand-like valve stained in 
haematoxylin–eosin solution.
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great variability in the morphology of the coronary 
venous system such as the localisation, angulation 
and diameter of the CS ostium, as well as the pre-
sence of Thebesian valve which can complicate or 
inhibit sinus cannulation. Anatomists and clinicians 
have tried to describe this region in a manner which 
would be useful for electrophysiologists. 
In the present investigation, the presence of The-
besian valve was observed in 77.5% of hearts, which 
is similar to previous studies. The Thebesian valve has 
been identified in a significant number of hearts exa-
mined by various researchers [2, 8]. In their study on 
54 hearts obtained from patients with atherosclerosis, 
cardiomyopathy, left ventricular enlargement and 
endocarditis, Mak et al. [11] observed the CS valve 
in 73% of specimens. Meanwhile, Pejkovic et al. [15] 
identified the Thebesian valve in 80% of their sample. 
The morphology of the cardiac sinus region in 
the current examination revealed several types of 
Thebesian valves which differed in conformation 
as well as in the proportion of ostium they cove-
red. Type V Thebesian valves were rather large and 
usually spanned a sizeable portion of the ostium. 
Tissues samples from the different valve types were 
fairly similar histologically with the exception of 
type II valves which contained cells with features 
similar to the conduction system of the heart. Katti 
and Patil [8] examined 50 autopsied hearts and 
observed great variability in the Thebesian valve, 
noting that in 20% of specimens it covered more 
than 60% of the ostium. They also examined the 
histological structure of the valves confirming its 
typical components: endocardium with collagen 
and muscular fibres [8].
The clinical implications of the topography of 
the CS region are not yet fully understood [1, 7, 12, 
13, 16]. Of the patients undergoing invasive cardiac 
procedures, CS cannulation is unsuccessful in 5–10% 
of individuals, although Mak et al. [11] believe that 
the incidence is underreported. Cao et al. [3] repor-
ted a case of complicated implantable cardiover-
ter-defibrillator procedure caused by a prominent 
Thebesian valve that required that implantation be 
made using an alternative venous approach due to 
the obstruction caused by the valve. Anh et al. [2] 
visually examined the CS of 98 individuals during 
pacemaker implantation and observed a Thebesian 
valve in 54% of patients, with 6% of these having an 
ostium that was more than 70% covered by a huge 
valve. To address this complication, direct visualisa-
tion and modern catheterisation techniques were 
employed allowing successful implantation to occur 
despite the obstruction provided by the large valve. 
Therefore visualisation and a clear understanding of 
the CS ostium morphology can improve the success 
rate of CS cannulation.
Potentially complicating features of the Thebesian 
valve include atypical histological features and large 
valve size, as observed in type V valves, which has 
the ability to occlude the venous sinus. Difficulties in 
advancing the catheter during cannulation of the CS 
may be due to atypical histological structure of the 
valves, represented by the strand type valve [6]. In 
the present sample the type II valves with strand like 
conformation contained cells similar to those found in 
the cardiac conduction system. The presence of cells 
of the conduction system of the heart in this type of 
Thebesian valve makes the risk of possible compli-
cations during cannulation higher as they could be 
a source of arrhythmias stemming from the ability 
of these cells to depolarise spontaneously. This latter 
hypothesis requires further scrutiny.
This study examined post-mortem heart tissue, 
and so observation cannot be directly generalisable 
to in vivo human hearts. The dynamic nature of the 
valve was not able to be observed thus it is hard to 
precisely determine how the variability in the mor-
phology of the Thebesian valve affects its function. 
Nonetheless, the findings presented in this investiga-
tion are important to further understand the anatomy 
of this region and how the various morphologies can 
affect invasive cardiac procedures.
CONCLUSIONS
This study highlights the variability in the structure 
of the CS ostium and suggests that a clear understan-
ding of the topography of this region is important for 
electrophysiologists. The type of Thebesian valve ob-
served can affect the success of invasive procedures. 
The fold-like Thebesian valve (type V) can complicate 
cannulation of the CS by obstructing access to the 
sinus. Similarly the atypical histological structure of 
the chord-like valve (type II) may complicate invasive 
cardiac procedures as the valve possess cells with 
conductive abilities and so the potential to induce 
arrhythmias. Thus a detailed knowledge of the CS 
region and understanding the potential implications 
of the morphology of this area may be pivotal in hel-
ping to plan and adapt procedural strategies during 
invasive cardiac procedures.
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